Brivaracetam Retention Rate and Seizure Outcomes in Patients with Drug-Resistant Focal Epilepsy Included in the Medical Need Program in Belgium: A Real-World, Multicenter, Chart Review

BACKGROUND: New treatments are needed for patients with drug-resistant epilepsy to improve seizure control without decreasing quality of life. OBJECTIVE: In Belgium, a Medical Need Program (MNP) was initiated to make a new antiepileptic drug (brivaracetam; high-affinity synaptic vesicle protein 2A l...

Descripción completa

Detalles Bibliográficos
Autores principales: Depondt, Chantal, Van Paesschen, Wim, van Rijckevorsel, Kenou, Leunikava, Iryna, Ferrière, France
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2021
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8324749/
https://www.ncbi.nlm.nih.gov/pubmed/34060026
http://dx.doi.org/10.1007/s40801-021-00246-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8324749/
https://www.ncbi.nlm.nih.gov/pubmed/34060026
http://dx.doi.org/10.1007/s40801-021-00246-7

Ejemplares similares